Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026Immunological Investigations

Therapeutic Cancer Vaccines: Classification, Mechanisms, Challenges and Future Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJuwei GaoYSYue SunZHZijing Han

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gao et al. (2026) studied this question.

synapsesocial.com/papers/6aabb6d85f706d05830e5932https://doi.org/10.1080/08820139.2026.2733761
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Personalized vaccines for cancer immunotherapy2018 · 1,176 citations
  2. 2INTerpath-001: Pembrolizumab with V940 (mRNA-4157) versus pembrolizumab with placebo for adjuvant treatment of high-risk stage II-IV melanoma.2024 · 22 citations
  3. 3Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy2025 · 27 citations
  4. 4Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation2025 · 61 citations
  5. 5The advent of clinical self-amplifying RNA vaccines2025 · 85 citations